WebbFor PCs, treatment with the THERAFLEX UV‐Platelet system resulted in an average of 7.02 log reduction in JEV infectivity at the standard UVC dose (0.20 J/cm2).Conclusions: The THERAFLEX MB‐Plasma and THERAFLEX UV‐Platelets systems effectively inactivated JEV in plasma or PCs, and thus these PI technologies could be an effective option to reduce … Webb1 nov. 2014 · Theraflex-UV (Macopharma, Tourcoing, France) is still under development. This method uses UVC, which acts directly on nucleic acids to induce pyrimidine dimers and block DNA replication [22], [23]. All three techniques have also been developed for plasma treatment. 3. Pathogen reduction
Pesquisa Portal Regional da BVS
WebbTheraflex UV-Platelets system is CE marked since 2009, but is not yet available for routine use [9]. Theraflex UV-Platelets system does not rely on photosensitive compounds but solely on irra-diation (wavelength 254 nm) that is not absorbed Table 1. Pathogen inactivation methods in blood components System Theraflex MB Plasma WebbTHERAFLEX UV-Platelets is a pathogen reduction technology for PCs based on ultraviolet (UV) light absorption by nucleic acids (DNA and RNA) [23]. This in turn causes the forma-tion of cyclobutane pyrimidine and pyrimidine pyrimidone dimers, which block the Preservation of optimal quality and efficacy in UV-C pathogen-reduced human platelet … devon live news uk
THERAFLEX ultraviolet C (UVC)-based pathogen reduction …
Webb6 maj 2024 · CONCLUSIONS:Both THERAFLEX UV-Platelets (UVC) and THERAFLEX MB-Plasma (MB/light) effectively reduce EBOV and MERS-CoV infectivity in platelets and plasma, respectively. Free full text Transfusion. 2024 Sep; 58(9): 2202–2207. Published online 2024 May 6. doi: 10.1111/trf.14652 PMCID: PMC7169708 PMID: 29732571 Webb4 feb. 2024 · The above in vitro antiviral study found a solution of 1 μM methylene blue and 40,000 lux of light inactivated SARS coronavirus in 30 minutes. In terms of safe oral dosages, I think it would be feasible to achieve in the bloodstream the 1 μM methylene blue concentration used in the antiviral study. WebbThis brief paper is based on the Coimbra ‘conference presentation by the moderator’, prior to the two main lectures on pathogen reduction treatment [PRT] of plasma. Being an educationist and teacher in core and having a great interest to simplify the message convey to conference' participants and readers I decided to maintain the slide format of … churchill quinn richtman \u0026 hamilton ltd